Oxyphen, Phentalene, Phen FX, and Red Vipers by Beta Labs, LTD: Recall - Contains DMAA

June 24, 2013

Audience: Consumers

ISSUE: Beta Labs, LTD is recalling Oxyphen XR (Lot #s 200910 and 200911), Phentalene (Lot # 58800512), Phen FX (Lot # 1205129), and Red Vipers (Lot # 1205128). The recall was initiated on June 15, 2013, after a review of recent FDA communications related to 1,3 dimethylamylamine (“DMAA”). The products are in capsule form and contain DMAA.

The products were sold via telephone in all fifty (50) United States. There have been no reports of adverse events associated with these Products to date. No other products distributed by Beta are subject to recall.

BACKGROUND: DMAA is commonly used as a stimulant, pre-workout, and weight loss ingredient in dietary supplement products. FDA has warned that DMAA is potentially dangerous to health (refer to Consumer Update below).  Ingestion of DMAA can elevate blood pressure and lead to cardiovascular problems.FDA has also warned that DMAA is not a dietary ingredient and thus, is not Dietary Supplement Health and Education Act (DSHEA) compliant.

RECOMMENDATION: Consumers who may have purchased the affected lot numbers of Oxyphen, Phentalene, Phen FX, and/or Red Vipers should immediately discontinue using the products and contact their health care professional if they have experienced any adverse effects. Consumers can contact Beta at accounting at betalabs.net or call 1- 877-283-1742, Monday – Friday, 10 a.m. – 5 p.m. CST to receive further instructions for returning the product(s), refunds, or with any questions.


[06/22/13 - Recall - Beta Labs]
[04/11/2013 - Consumer Update - FDA]

View comments

Hide
(web4)